NORD Stock Chart & Stats
$4.10
$0.15(1.71%)
At close: 4:00 PM EST
$4.10
$0.15(1.71%)
Day’s Range― - ―
52-Week Range$1.48 - $5.95
Previous CloseN/A
Volume450.00
Average Volume (3M)1.31K
Market Cap
$46.28M
Enterprise Value$68.38M
Total Cash (Recent Filing)$189.30K
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.34
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding18,888,395
10 Day Avg. Volume1,209
30 Day Avg. Volume1,311
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)0.73
Price to Sales (P/S)8744.81
P/FCF Ratio-34.04
Enterprise Value/Market Cap1.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-16.38
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nordicus Partners News
NORD FAQ
What was Nordicus Partners’s price range in the past 12 months?
Nordicus Partners lowest stock price was $1.48 and its highest was $5.95 in the past 12 months.
What is Nordicus Partners’s market cap?
Nordicus Partners’s market cap is $46.28M.
When is Nordicus Partners’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nordicus Partners’s earnings last quarter?
Currently, no data Available
Is Nordicus Partners overvalued?
According to Wall Street analysts Nordicus Partners’s price is currently Overvalued.
Does Nordicus Partners pay dividends?
Nordicus Partners pays a N/A dividend of $12.5 which represents an annual dividend yield of N/A. See more information on Nordicus Partners dividends here
What is Nordicus Partners’s EPS estimate?
Nordicus Partners’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nordicus Partners have?
Nordicus Partners has 18,888,395 shares outstanding.
What happened to Nordicus Partners’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nordicus Partners?
Currently, no hedge funds are holding shares in NORD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nordicus Partners
Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.
Technical Analysis
Ownership Overview
Options Prices
Currently, No data available
---